Enter Note Done
Go to previous page in this tab
Session
  • Presentation | P05 - Neuroendocrinology and Pituitary: Growth Hormone and Acromegaly - Clinical
  • Poster Abstract
  • Bookmark Icon
  • Predictors of Response to Oral Octreotide Capsules in Patients With Acromegaly in a Large Prospective International Trial [Board No. THU-057]
  • Schedule
    Notes
  • Board no. THU-057
    THU-057
    Set Timezone

Authors

Maria Fleseriu, MD1, Alexander Dreval, MD, PhD Prof2, Yulia Pokramovich, MD2, Irina Bondar, MD3, Elena Isaeva, PhD4, Djuro P. Macut, MD, PhD5, Mark E. Molitch, MD6, Nina Vasiljevna Leonova, MD7, Gerald Raverot, MD,PhD8, Asi Haviv, MD9, Nienke Biermasz, MD,PhD10, Christian Joseph Strasburger, MD11, Shlomo Melmed, MB ChB12.
1Oregon Health & Science University, Portland, OR, USA, 2M.F. Vladimirsky Moscow Regional Research Clinical Institute, Moscow, Russian Federation, 3Novosibirsk State Medical University, Novosibirsk, Russian Federation, 4Interregional Clinical Diagnostic Center, Kazan, Russian Federation, 5Faculty of Medicine, University of Belgrade, Belgrade, Serbia, 6Northwestern University Feinberg School of Medicine, Chicago, IL, USA, 7Atrium Multidisciplinary Medical Clinic, Barnaul, Altai Region, Russian Federation, 8Hospices Civils de Lyon, Lyon Cedex 03, France, 9Amryt Pharma Plc (fka Chiasma, Inc.), Needham, MA, USA, 10Leiden University Medical Center, Leiden, Netherlands, 11Charite- Universitätsmedizin, Campus Mitte, Berlin, Germany, 12Cedars Sinai Medical Center, Los Angeles, CA, USA.

Disclosures

M. Fleseriu: Consulting Fee; Self; Amryt (fka Chiasma), Ipsen, Ionis Pharmaceuticals Inc., Recordati, Pfizer, Inc.. Research Investigator; Self; Amryt(fka Chiasma), Crinetics, Ionis Pharmaceuticals Inc., Recordati. Other; Self; Deputy Editor at EJE. A. Dreval: Research Investigator; Self; Research Investigator: Amryt(fka Chiasma). Y. Pokramovich: Research Investigator; Self; Research Investigator: Amryt(fka Chiasma). I. Bondar: Research Investigator; Self; Amryt(fka Chiasma). E. Isaeva: Research Investigator; Self; Chiasma. D.P. Macut: Research Investigator; Self; Principle Investigator: Amryt(fka Chiasma). Speaker; Self; Novartis Pharmaceuticals, Novo Nordisk, Sanofi, Pfizer, Inc., (spouse) Novo Nordisk. Other; Self; member of the Executive Committee of the European Society of Endocrinology (ESE). M.E. Molitch: Consulting Fee; Self; Corcept, Janssen Research & Development Company, Merck, Novo Nordisk, Pfizer, Inc., Novartis Pharmaceuticals. Grant Recipient; Self; Amryt(fka Chiasma), Crinetics, Ionis Pharmaceuticals Inc.. Research Investigator; Self; Bayer, Inc. N.V. Leonova: Research Investigator; Self; Chiasma. G. Raverot: Consulting Fee; Self; Pfizer, Inc., Recordati Rare Diseases, Ipsen. Research Investigator; Self; Chiasma, Pfizer, Inc., Novartis Pharmaceuticals. Speaker; Self; Ipsen, Pfizer, Inc., Recordati Rare Diseases. A. Haviv: Employee; Self; Amryt(fka Chiasma). N. Biermasz: Advisory Board Member; Self; Recordati, Pfizer, Inc., Macro Registry. Grant Recipient; Self; Amryt(fka Chiasma). C.J. Strasburger: Advisory Board Member; Self; Sandoz, Ipsen, Recordati. Consulting Fee; Self; Ascendis, Amryt(fka Chiasma), Novo Nordisk, Merck, Sandoz, Recordati. Speaker; Self; Ipsen, Novo Nordisk, HRA Pharmaceuticals. S. Melmed: Advisory Board Member; Self; Ionis Pharmaceuticals Inc., Crinetics. Consulting Fee; Self; Ipsen. Grant Recipient; Self; Pfizer, Inc..

Session Types
Main Session
Discussion